About TMC > Executive Biographies > Mark McPhee, MD, MHCM
Mark McPhee, MD, MHCM
Executive Vice President, Clinical Coordination
As Executive Vice President of Clinical Coordination, Mark McPhee, MD,
MHCM, is responsible for direct oversight of Nursing, Behavioral Health
Services, Practice Management and Professional Services. He also
provides leadership in the coordination of discharge planning,
inpatientoutpatient handoffs, chronic disease management support,
physician alignment, care coordination across a continuum of service and
those enterprises that master customer service throughout the patient
experience and particularly in the ambulatory care arena.
A native of Kansas City, Dr. Mark McPhee is a magna cum laude
graduate of Pomona College in Claremont, California-concentrating in
biology and literature. He was class valedictorian and a summa cum laude
graduate of the University Kansas School of Medicine. He did his
internship and residency in Internal Medicine at Beth Israel Hospital as
well as a fellowship in Gastroenterology at Massachusetts General
Hospital. He completed a master’s degree in Health Care Management at
Prior to joining TMC, Dr. McPhee was a founding partner of
Mid-America Gastro-Intestinal Consultants, GI Diagnostics, Inc. and
Plaza Gastroenterology Associates. He has served as Saint Luke’s Health
System as Chief Academic Officer, Chief Medical Officer/Vice President
for Medical Affairs and finally as Senior Vice President and Chief
Operating Officer. During his administrative leadership at Saint Luke’s,
the hospital was a recipient of the Missouri Quality Award three times
and also the Malcolm Baldrige National Quality Award in 2003 – the
second such award nationally in the health care category. His academic
roles have included, Director of the GI Endoscopy Unit at the University
of Kansas and then, Chief of the Division of Gastroenterology, Chairman
of the Department of Medicine and Associate Dean/Director of Medical
Education and Research at Saint Luke’s Hospital.
In 2009, Dr. McPhee joined the Cleveland Clinic Executive Team in
2009 as Chief Operating Officer for Cleveland Clinic Abu Dhabi (CCAD)
and was appointed interim Chief Executive Officer in October, 2010.
During his tenure with CCAD, the new hospital project remained
substantially (>90%) on time and under budget.
Academically, Dr. McPhee’s research interests have been in drug
treatment of inflammatory bowel disease and in disorders of the
gallbladder and bile ducts and pancreas.
In addition to his clinical, academic and administrative roles, Dr.
McPhee served as a delegate to the American Medical Association for 16
years and in various roles as Committee Chair, Governing Board Members
and Officer with the American Gastroenterological Association, the
American Digestive Health Foundation and the Foundation for Digestive
Health and Nutrition. He has also served on the Civic Council of Greater
Kansas City and on the boards of multiple organizations devoted to the
arts, medicine, higher education and community welfare.